Pöllmann G, Kullich W, Klein G
Sonderkrankenanstalt für rheumatische Erkrankungen und Herzkreislaufkrankheiten der Pensionsversicherungsanstalt für Arbeiter, Saalfelden.
Wien Med Wochenschr. 1997;147(16):382-7.
Therapy of hyperuricemia and gout has to depend on pathogenesis and stage of the disease. Dietary regimen are in the forefront in treatment of asymptomatic hyperuricemia. Uric acid lowering drugs can only be supported in repeated serum-measures from 9 mg/dl up. The therapy of an acute attack of gout primarily is done with non-steroidal antiinflammatory drugs, in rare cases with colchicine or corticoids. Gouty arthritis in intermission, independent of the extent of hyperuricemia, as well as chronic gout are indications for an uric acid lowering pharmacotherapy, usually for life. A special therapeutic challenge arises out of renal complications and the frequent association with the metabolic syndrome.
高尿酸血症和痛风的治疗必须取决于疾病的发病机制和阶段。饮食疗法在无症状高尿酸血症的治疗中处于首要地位。只有在血清尿酸反复测量值达到9mg/dl及以上时,才使用降尿酸药物。痛风急性发作的治疗主要使用非甾体类抗炎药,极少数情况下使用秋水仙碱或皮质类固醇。痛风间歇期的关节炎,无论高尿酸血症的程度如何,以及慢性痛风,都是进行降尿酸药物治疗的指征,通常需要终身治疗。肾脏并发症以及与代谢综合征的频繁关联带来了特殊的治疗挑战。